Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02438514 · ClinicalTrials.gov registry record
Biological Biomarkers in MOMS Partnership
A clinical trial, sponsored by Yale University.
- Terminated
- Registry status
- 20
- Enrollment target
NCT02438514: Clinical Trial study, sponsored by Yale University.
NCT02438514 is a clinical trial that was terminated before completion, run by Yale University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02438514 was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The investigators propose to evaluate the potential utility of stress-related biomarkers obtained via dried blood spots (DBS) and retinal scans by collecting new data from mothers and children within the New Haven MOMS Partnership, a well-established community-partnered research setting. The proposed research could greatly advance the application of stress-related biomarkers within community-based research by increasing our understanding of how stress, trauma, and depression influence biology in childhood and adulthood, as measured using minimally-invasive approaches.
Primary Outcome
Feasibility outcome
Interventions
- OTHER Biological Sample Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-11 |
| Est. Completion | 2019-11 |
Why NCT02438514 stopped before completion
NCT02438514 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Biological Sample Collection is the first listed.
NCT02438514 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02438514 about?
NCT02438514 is a clinical study titled "Biological Biomarkers in MOMS Partnership". The investigators propose to evaluate the potential utility of stress-related biomarkers obtained via dried blood spots (DBS) and retinal scans by collecting new data from mothers and children within the New Haven MOMS Partnership, a well-established community-partnered research setting. The propose...
What is the current status of trial NCT02438514?
This trial is currently terminated. The enrollment target is 20 participants. The study started on 2014-11. Estimated completion is 2019-11.
What interventions are being tested in trial NCT02438514?
The interventions under investigation include: Biological Sample Collection (OTHER).
Who is sponsoring clinical trial NCT02438514?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia